Filing Details
- Accession Number:
- 0001968202-23-000042
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-15 16:02:48
- Reporting Period:
- 2023-11-13
- Accepted Time:
- 2023-11-15 16:02:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1796226 | J Andrew Murphy | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Research | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-11-13 | 20,000 | $270.43 | 79,421 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-11-13 | 13,508 | $795.69 | 65,913 | No | 4 | F | Direct | |
Common Stock | Disposition | 2023-11-14 | 752 | $794.57 | 65,161 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-14 | 347 | $795.38 | 64,814 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-14 | 204 | $797.79 | 64,610 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-14 | 1,614 | $798.63 | 62,996 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-14 | 1,601 | $799.48 | 61,395 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-14 | 382 | $800.55 | 61,013 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-14 | 877 | $801.56 | 60,136 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-14 | 347 | $802.63 | 59,789 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-14 | 330 | $803.38 | 59,459 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-14 | 19 | $804.89 | 59,440 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-11-14 | 19 | $805.00 | 59,421 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2023-11-13 | 20,000 | $0.00 | 20,000 | $270.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,000 | 2023-12-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,310 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 9, 2023.
- Represents volume-weighted average price of sales of 752 shares of Company stock on November 14, 2023 at prices ranging from $794.03 to $794.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
- Represents volume-weighted average price of sales of 347 shares of Company stock on November 14, 2023 at prices ranging from $795.02 to $795.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
- Represents volume-weighted average price of sales of 204 shares of Company stock on November 14, 2023 at prices ranging from $797.09 to $797.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
- Represents volume-weighted average price of sales of 1,614 shares of Company stock on November 14, 2023 at prices ranging from $798.00 to $798.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
- Represents volume-weighted average price of sales of 1,601 shares of Company stock on November 14, 2023 at prices ranging from $799.00 to $799.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
- Represents volume-weighted average price of sales of 382 shares of Company stock on November 14, 2023 at prices ranging from $800.31 to $800.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
- Represents volume-weighted average price of sales of 877 shares of Company stock on November 14, 2023 at prices ranging from $801.01 to $801.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
- Represents volume-weighted average price of sales of 347 shares of Company stock on November 14, 2023 at prices ranging from $802.17 to $802.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
- Represents volume-weighted average price of sales of 330 shares of Company stock on November 14, 2023 at prices ranging from $803.18 to $803.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 14, 2023 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.